M. R. Gilbert, M. Wang, K. D. Aldape, R. Stupp, M. E. Hegi et al., Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial, J Clin Oncol, vol.31, issue.32, pp.4085-91, 2013.

R. Stupp, W. P. Mason, M. J. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, N Engl J Med, vol.352, issue.10, pp.987-96, 2005.

O. Van-tellingen, B. Yetkin-arik, M. C. De-gooijer, P. Wesseling, T. Wurdinger et al., Overcoming the blood-brain tumor barrier for effective glioblastoma treatment, Drug Resist Updat, vol.19, pp.1-12, 2015.

S. P. Weathers and M. R. Gilbert, Advances in treating glioblastoma. F1000Prime Rep, 2006.

C. Alifieris and D. T. Trafalis, Glioblastoma multiforme: Pathogenesis and treatment, Pharmacol Ther, vol.152, pp.63-82, 2015.

F. Allahdini, A. Amirjamshidi, M. Reza-zarei, and M. Abdollahi, Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival? World Neurosurg, vol.73, pp.128-162, 2010.

M. Khoshnevis, C. Carozzo, C. Bonnefont-rebeix, S. Belluco, O. Leveneur et al., Development of induced glioblastoma by implantation of a human xenograft in Yucatan minipig as a large animal model, J Neurosci Methods, vol.282, pp.61-69, 2017.

A. F. Hottinger, R. Stupp, and K. Homicsko, Standards of care and novel approaches in the management of glioblastoma multiforme, Chin J Cancer, vol.33, issue.1, pp.32-41, 2014.

M. E. Davis and . Glioblastoma, Overview of Disease and Treatment, Clin J Oncol Nurs, vol.20, issue.5, p.2, 2016.

J. L. Fisher, J. A. Schwartzbaum, M. Wrensch, and J. L. Wiemels, Epidemiology of Brain Tumors, Neurol Clin, vol.25, issue.4, pp.867-90, 2007.

D. Krex, B. Klink, C. Hartmann, A. Von-deimling, T. Pietsch et al., Long-term survival with glioblastoma multiforme, Brain, vol.130, issue.10, pp.2596-606, 2007.

A. Omuro and L. M. Deangelis, Glioblastoma and Other Malignant Gliomas, JAMA, vol.310, issue.17, p.1842, 2013.

B. Bølge-tysnes and R. Mahesparan, Biological Mechanisms of Glioma Invasion and Potential Therapeutic Targets, J Neurooncol, vol.53, issue.2, pp.129-176, 2001.

K. Urbanska, J. Sokolowska, M. Szmidt, and P. Sysa, Glioblastoma multiforme-An overview, Wspolczesna Onkol, vol.18, issue.5, pp.307-319, 2014.

S. Kesari, Understanding glioblastoma tumor biology: The potential to improve current diagnosis and treatments, Seminars in Oncology. W.B. Saunders, p.2, 2011.

C. Y. Lee, Strategies of temozolomide in future glioblastoma treatment, Onco Targets Ther, vol.10, pp.265-70, 2017.

T. Weiss, M. Weller, and P. Roth, Immunological effects of chemotherapy and radiotherapy against brain tumors, Expert Rev Anticancer Ther, vol.16, issue.10, pp.1087-94, 2016.

C. Tso, W. A. Freije, A. Day, Z. Chen, B. Merriman et al., Distinct Transcription Profiles of Primary and Secondary Glioblastoma Subgroups, Cancer Res, vol.66, issue.1, pp.159-67, 2006.

B. Mujokoro, M. Adabi, E. Sadroddiny, M. Adabi, and M. Khosravani, Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review, Mater Sci Eng C, vol.69, pp.1092-102, 2016.

A. A. Thomas, M. S. Ernstoff, and C. E. Fadul, Immunotherapy for the treatment of glioblastoma, Cancer J, vol.18, issue.1, pp.59-68, 2012.

M. S. Walid, Prognostic factors for long-term survival after glioblastoma, Perm J, vol.12, issue.4, pp.45-53, 2008.

P. Beauchesne, V. Bernier, C. Carnin, L. Taillandier, M. Djabri et al., Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy, Neuro Oncol, vol.12, issue.6, pp.595-602, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00744215

A. Brandes, M. Soesan, and M. Fiorentino, Medical treatment of high grade malignant gliomas in adults: an overview, Anticancer Res, vol.11, issue.2, pp.719-746, 1991.

C. Gzell, M. Back, H. Wheeler, D. Bailey, and M. Foote, Radiotherapy in Glioblastoma: the Past, the Present and the Future, Clin Oncol, vol.29, issue.1, pp.15-25, 2017.

M. Suzuki, K. Nakamatsu, S. Kanamori, M. Okumra, T. Uchiyama et al., Feasibility Study of the Simultaneous Integrated Boost (SIB) Method for Malignant Gliomas Using Intensity-modulated Radiotherapy (IMRT), Jpn J Clin Oncol, vol.33, issue.6, pp.271-278, 2003.

M. D. Walker, T. A. Strike, and G. E. Sheline, An analysis of dose-effect relationship in the radiotherapy of malignant gliomas, Int J Radiat Oncol, vol.5, issue.10, pp.1725-1756, 1979.

O. M. Salazar, P. Rubin, M. D. Feldstein, M. L. Pizzutiello, and R. , High dose radiation therapy in the treatment of malignant gliomas: Final Report, Int J Radiat Oncol, vol.5, issue.10, pp.1733-1773, 1979.

M. D. Walker, A. E. Hunt, W. E. Maccarty, C. S. Mahaley, M. S. Mealey et al., Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas, J Neurosurg, vol.49, issue.3, pp.333-376, 1978.

J. E. Chang, D. Khuntia, H. I. Robins, and M. P. Mehta, Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme, Clin Adv Hematol Oncol, vol.5, issue.11, pp.907-922, 2007.

E. Barbarite, J. T. Sick, E. Berchmans, A. Bregy, A. H. Shah et al., The role of brachytherapy in the treatment of glioblastoma multiforme, Neurosurg Rev, vol.40, issue.2, p.27180560, 2017.

J. D. Waters, B. Rose, D. D. Gonda, D. J. Scanderbeg, M. Russell et al., Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma, J Neurooncol, vol.113, issue.3, p.23673513, 2013.

J. F. Dempsey, J. A. Williams, J. B. Stubbs, T. J. Patrick, and J. F. Williamson, Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins

, Int J Radiat Oncol Biol Phys, vol.42, issue.2, pp.215-221, 1998.

S. B. Tatter, E. G. Shaw, M. L. Rosenblum, K. C. Karvelis, L. Kleinberg et al., An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: Multicenter safety and feasibility trial, J Neurosurg, vol.99, issue.2, pp.297-303, 2003.

N. N. Nupponen and H. Joensuu, Molecular pathology of gliomas, Curr Diagnostic Pathol, vol.12, issue.5, pp.394-402, 2006.

K. Kelley, J. Knisely, M. Symons, and R. Ruggieri, Radioresistance of Brain Tumors. Cancers (Basel), vol.8, p.42, 2016.

J. Knisely and R. S. , Importance of hypoxia in the biology and treatment of brain tumors. Neuroimaging Clin N Am, vol.12, pp.32-33, 2002.

D. R. Collingridge, J. M. Piepmeier, S. Rockwell, and J. Knisely, Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue, Radiother Oncol, vol.53, issue.2, pp.127-158, 1999.

I. S. Miller, S. Didier, D. W. Murray, T. H. Turner, M. Issaivanan et al., Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia, PLoS One, vol.9, issue.5, p.95885, 2009.

B. A. Castro and M. K. Aghi, Getting more out of radiation therapy in glioblastoma, Neuro Oncol, vol.16, issue.1, pp.4-6, 2014.

S. Villà, C. Balañà, and S. Comas, Radiation and concomitant chemotherapy for patients with glioblastoma multiforme, Chin J Cancer, vol.33, issue.1, pp.25-31, 2014.

N. Laperriere, L. Zuraw, and G. Cairncross, Radiotherapy for newly diagnosed malignant glioma in adults: A systematic review, Radiother Oncol, vol.64, issue.3, pp.78-84, 2002.

D. Amelio and M. Amichetti, Radiation therapy for the treatment of recurrent glioblastoma: an overview. Cancers (Basel), vol.4, pp.257-80, 2012.

G. Minniti, D. Amelio, M. Amichetti, M. Salvati, R. Muni et al., Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide, Radiother Oncol, vol.97, issue.3, pp.377-81, 2010.

J. Nijsen, J. Seppenwoolde, T. Havenith, C. Bos, C. Bakker et al., Liver Tumors: MR Imaging of Radioactive Holmium Microspheres-Phantom and Rabbit Study, Radiology, vol.231, issue.2, pp.491-500, 2004.

M. Vente, T. C. De-wit, . Van-den, M. Bosch, W. Bult et al., Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: Technical aspects studied in a large animal model, Eur Radiol, vol.20, issue.4, pp.862-871, 2010.

S. W. Zielhuis, J. Nijsen, J. Seppenwoolde, C. Bakker, G. C. Krijger et al., Long-term toxicity of holmium-loaded poly(l-lactic acid) microspheres in rats, Biomaterials, vol.28, issue.31, pp.4591-4600, 2007.

Y. D. Hong, K. B. Park, B. S. Jang, S. J. Choi, S. M. Choi et al., Holmium-166-DTPA as a liquid source for endovascular brachytherapy, Nucl Med Biol, vol.29, issue.8, pp.329-332, 2002.

R. Huh, Y. S. Park, J. D. Lee, Y. S. Chung, Y. G. Park et al., Therapeutic effects of Holmium-166 chitosan complex in rat brain tumor model, Yonsei Med J, vol.46, issue.1, pp.51-60, 2005.

L. Marcon, H. Gehan, M. Khoshnevis, L. Marmuse, C. Carozzo et al., Synthesis of Highly-loaded Holmium-165 Siloxane Particles for Brachytherapy of Brain Cancer and Injectability Evaluation in Healthy Pig, J Nanomed Nanotechnol, vol.8, issue.5, p.460, 2017.

L. Selek, E. Seigneuret, G. Nugue, D. Wion, M. F. Nissou et al., Imaging and histological characterization of a human brain xenograft in pig: The first induced glioma model in a large animal, J Neurosci Methods, vol.221, pp.159-65, 2014.

, MG ATCC ® HTB-14 TM Homo sapiens brain Likely glioblastom

R. Brown, M. Bardiès, and X. Franceries, Treatment planning of microbrachytherapy with 3D NSGA-II, IFMBE Proceedings, pp.450-453, 2017.

N. Srinivas and K. Deb, Muiltiobjective Optimization Using Nondominated Sorting in Genetic Algorithms, Evol Comput, vol.2, issue.3, pp.221-269, 1994.

C. Buonerba, D. Lorenzo, G. Marinelli, A. Federico, P. Palmieri et al., A comprehensive outlook on intracerebral therapy of malignant gliomas, Crit Rev Oncol Hematol, vol.80, issue.1, pp.54-68, 2011.

M. Y. Chen, R. R. Lonser, P. F. Morrison, L. S. Governale, and E. H. Oldfield, Variables affecting convectionenhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time, J Neurosurg, vol.90, issue.2, pp.315-335, 1999.

B. D. Semple, K. Blomgren, K. Gimlin, D. M. Ferriero, and L. J. Noble-haeusslein, Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol, pp.106-107, 2013.

D. W. Howells, M. J. Porritt, S. S. Rewell, O. Collins, V. Sena et al., Different Strokes for Different Folks: The Rich Diversity of Animal Models of Focal Cerebral Ischemia, J Cereb Blood Flow Metab, vol.30, issue.8, pp.1412-1443, 2010.

L. Chen, Y. Zhang, J. Yang, J. P. Hagan, and M. Li, Vertebrate animal models of glioma: Understanding the mechanisms and developing new therapies, Biochim Biophys Acta-Rev Cancer, vol.1836, issue.1, pp.158-65, 2013.

V. L. Jacobs, P. A. Valdes, W. F. Hickey, D. Leo, and J. A. , Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model, ASN Neuro, vol.3, issue.3, p.63, 2011.

M. Candolfi, J. F. Curtin, W. S. Nichols, A. G. Muhammad, G. D. King et al., Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression, J Neurooncol, vol.85, issue.2, p.17874037, 2007.

M. Ammirati, N. Vick, Y. Liao, I. Ciric, and M. Mikhael, Effect of the Extent of Surgical Resection on Survival and Quality of Life in Patients with Supratentorial Glioblastomas and Anaplastic Astrocytomas. Neurosurgery, vol.21, pp.201-207, 1987.

A. A. Brandes, A. Tosoni, F. Spagnolli, G. Frezza, M. Leonardi et al., Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology, Neuro Oncol, vol.10, issue.3, pp.361-368, 2008.

P. N. Plowman, Stereotactic radiosurgery VIII. The classification of postradiation reactions, Br J Neurosurg, vol.13, issue.3, pp.256-64, 1999.

S. Patel, J. C. Breneman, R. E. Warnick, R. E. Albright, W. D. Tobler et al., Permanent Iodine-125 Interstitial Implants for the Treatment of Recurrent Glioblastoma Multiforme, Neurosurgery, vol.46, issue.5, pp.1123-1153, 2000.

Y. H. Lee, Effect of Holmium-166 Injection into Hepatocellular Carcinomas (SK-HEP1) Heterotransplanted in Mice, J Korean Radiol Soc, vol.38, issue.1, p.83, 1998.

W. Bult, S. Kroeze, M. Elschot, P. R. Seevinck, F. J. Beekman et al., Intratumoral Administration of Holmium-166 Acetylacetonate Microspheres: Antitumor Efficacy and Feasibility of Multimodality Imaging in Renal Cancer, PLoS One, vol.8, issue.1, 2013.

Y. S. Suzuki, Y. Momose, N. Higashi, A. Shigematsu, K. B. Park et al., Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice, J Nucl Med, vol.39, issue.12, pp.2161-2167, 1998.